Live Quote · NASDAQVCREHealthcare· Biotechnology

Vicore Pharma Holding AB

$9.41▼ 5.09%($-0.50)
MKT CAP $265.67MNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
41/100
▌ Weak
47
Valuation
40
Profitability
10
Growth
80
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VCRE research report →

Analyst Price Target
$25.00+165.8% vs. today

Range $25 – $25

Price Chart

-42.09% · this period
$16.25$12.46$8.66Jul 06Sep 14Nov 20
52-Week Range15% of range
Low
$7.88
Current
$9.41
High
$17.80